Hong Kong stock market anomaly: Fosun Pharmaceutical (02196.HK) rises by over 4%, with Morgan Stanley stating that the company's innovative drug pipeline value is underestimated. It is expected to reach a target price of 33 Hong Kong dollars.
According to the Wise Finance APP, Fosun Pharma (02196.HK) has risen by more than 4%, as of the time of writing, the increase is 4.16%, reaching 27.54 Hong Kong dollars, with a trading volume of 5.14 billion Hong Kong dollars.
Latest
2 m ago
